129 related articles for article (PubMed ID: 37177806)
1. Serum CA125 as a biomarker for dysmenorrhea in adenomyosis.
Tang Y; Wen MB; Xiang RM; Yang MT; Shu B; Xu F; Li J; Hu HQ; Shi Q
Int J Gynaecol Obstet; 2023 Oct; 163(1):131-139. PubMed ID: 37177806
[TBL] [Abstract][Full Text] [Related]
2. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
3. Preoperative CA125 as a risk factor for symptom recurrence of adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery.
Tang Y; Ming-Tao Y; Xiang RM; Xu W; Zhang RY; Weng MB; Tang FX; Hu HQ; Xu F; Li J; Shi Q
Int J Hyperthermia; 2022; 39(1):1164-1169. PubMed ID: 36075579
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic excision of symptomatic myometrial adenomyosis: feasibility and effectiveness.
Xia W; Zhang D; Zhu Q; Zhang H; Yang S; Ma J; Pan H; Tong T; Sun J; Zhang J
BJOG; 2017 Sep; 124(10):1615-1620. PubMed ID: 28544260
[TBL] [Abstract][Full Text] [Related]
5. Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.
Zheng R; Zeng D; Wan TT; Guo WB; Guo Y; Liu MJ
Diagn Interv Radiol; 2018 Nov; 24(6):364-371. PubMed ID: 30373724
[TBL] [Abstract][Full Text] [Related]
6. CA125 modified by PLT and NLR improves the predictive accuracy of adenomyosis-derived pelvic dense adhesion.
Jiang C; Liu C; Guo J; Chen L; Luo N; Qu X; Yang W; Ren Q; Cheng Z
Medicine (Baltimore); 2017 May; 96(19):e6880. PubMed ID: 28489790
[TBL] [Abstract][Full Text] [Related]
7. Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients.
Huang BS; Seow KM; Tsui KH; Huang CY; Lu YF; Wang PH
Taiwan J Obstet Gynecol; 2012 Jun; 51(2):212-6. PubMed ID: 22795096
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma.
Kil K; Chung JE; Pak HJ; Jeung IC; Kim JH; Jo HH; Kim MR
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():131-5. PubMed ID: 25577553
[TBL] [Abstract][Full Text] [Related]
9. Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis.
Liu S; Peng C; Wang Z; Zhou X; Zhang S; Li G; Yang B
J Obstet Gynaecol Res; 2023 Nov; 49(11):2753-2760. PubMed ID: 37614048
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological characteristics of suspected adenomyosis in the Chinese physical examination population: a nested case-control study.
Huang Y; Su X; Chen K; Zhang L; Xu W; Pu Y; Xu F; Gong R; Zhang J; Nie Y; Shi Q
BMJ Open; 2024 Jan; 14(1):e074488. PubMed ID: 38216177
[TBL] [Abstract][Full Text] [Related]
11. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia.
Li Z; Li X; Lin M; Qiu S; Wang L; Lai L; Luo X; Mo Z; Dong G; Lyu G; Li S
Int J Hyperthermia; 2022; 39(1):1335-1343. PubMed ID: 36257919
[TBL] [Abstract][Full Text] [Related]
13. Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy.
Li X; Liu X; Guo SW
J Obstet Gynaecol Res; 2014 Feb; 40(2):485-94. PubMed ID: 24148010
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
[No Abstract] [Full Text] [Related]
15. Efficacy of Transabdominal Ultrasound-guided Percutaneous Microwave Ablation in the Treatment of Symptomatic Adenomyosis: A Retrospective Cohort Study.
Li S; Li Z; Lin M; Li X; Gao L; Qiu J; He J; Zhang J; Lyu G
J Minim Invasive Gynecol; 2023 Feb; 30(2):137-146. PubMed ID: 36384213
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the relationship between MRI imaging characteristics and clinical symptoms and therapeutic efficacy in adenomyosis patients].
Han XT; Guo HY; Wang F; Gao XR; Liu L; Wang ML
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):343-350. PubMed ID: 37217341
[No Abstract] [Full Text] [Related]
17. Relationship between the serum cancer antigen 125 level and the weight of surgically enucleated adenomyosis.
Itagaki H; Nishida M; Kodaira Y; Sakanaka M; Ichikawa R; Arai Y; Satoh T
J Obstet Gynaecol; 2022 Aug; 42(6):2064-2068. PubMed ID: 35653768
[TBL] [Abstract][Full Text] [Related]
18. CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis.
Yang F; Wang Q; Ma R; Deng F; Liu J
J Multidiscip Healthc; 2024; 17():251-261. PubMed ID: 38250313
[TBL] [Abstract][Full Text] [Related]
19. Application of elastography to diagnose adenomyosis and evaluate the degree of dysmenorrhea: a prospective observational study.
Ren Q; Dong X; Yuan M; Jiao X; Sun H; Pan Z; Wang X; Tao G; Guoyun W
Reprod Biol Endocrinol; 2023 Oct; 21(1):98. PubMed ID: 37884924
[TBL] [Abstract][Full Text] [Related]
20. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis.
Guo SW; Mao X; Ma Q; Liu X
Fertil Steril; 2013 Jan; 99(1):231-240. PubMed ID: 22999795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
